12:00 AM
 | 
Jun 08, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

UCB, Pfizer sales and marketing update

Pfizer launched Toviaz fesoterodine 4 and 8 mg tablets in the U.S. for once-daily...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >